c; Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, Belgium dWe report the crystal structure of the M2 ectodomain (M2e) in complex with a monoclonal antibody that binds the amino terminus of M2. M2e extends into the antibody binding site to form an N-terminal -turn near the bottom of the paratope. This M2e folding differs significantly from that of M2e in complex with an antibody that binds another part of M2e. This suggests that M2e can adopt at least two conformations that can elicit protective antibodies.
Human influenza viruses can escape antibody-mediated immunity by varying the antigenic sites in their surface antigens that are most prone to virus neutralization. Vaccines that elicit antibody responses against conserved surface-exposed antigens, such as the stem region of influenza hemagglutinin or M2e, can protect against multiple influenza virus subtypes (1). A potential clinical benefit of M2e-based vaccines can be inferred from a challenge study in human volunteers, which showed that injection of human monoclonal antibody (MAb) TCN-032 directed against M2e 1 day after inoculation of an H3N2 influenza virus resulted in reduced clinical signs and virus shedding compared to placebo treatment (2).M2e corresponds to the surface exposed amino-terminal part of M2 and is 23 amino acid residues long (3). The first nine amino acid residues of M2 are extremely conserved across all reported influenza A viruses. Human and murine M2e-specific MAbs that recognize different parts of M2e have been described, but how these interact with M2e is largely unknown (4-6). Here, we report the crystal structure of M2e in complex with a Fab fragment from a MAb that binds to the highly conserved N-terminal part of M2.The ethical committee of Ghent University approved this mouse protection study. We isolated MAb148 from a BALB/c mouse that had been immunized with a recombinant tetrameric protein of M2e using conventional hybridoma technology (7). Intraperitoneal injection of 200 g of this IgG1 MAb protected mice against a potentially lethal challenge with an H1N1 virus (Fig. 1A). To identify the epitope of MAb148, we transfected a series of alanine mutants of M2 into HEK293T cells. Transfected cells were subsequently fixed and used in an enzyme-linked immunosorbent assay (ELISA). This analysis revealed that M2 residues Ser2, Leu3, Leu4, and Thr5 are critical for MAb148 binding (Fig. 1B). A similar N-proximal epitope in M2e was reported for human MAb TCN-031 and -032 (8). ELISA analysis using wells coated with M2e peptide variants showed MAb148 binding was indifferent to most of the sequence variation in the M2e segment spanning residues 9 to 20 (Fig. 1C). However, we noted reduced binding to the M2e peptide derived from A/Hong Kong/485/97 (Fig. 1C). Also a shorter M2e peptide (SLLTEVETPIRN) proved less accessible for MAb148 binding (Fig. 1C), though in solution this peptide competed with MAb148 for binding the coating full-length M2e peptide as efficiently as full-length M2e (Fig. 1D), suggesting that reduced re...